Full title: Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions Abstract: Objective Pharmacogenomics evaluations of variability in drug metabolic processes may be useful for making individual drug response predictions. We present an approach to deriving ‘phenotype scores’ based on existing pharmacogenomics knowledge and a patient's genomics data. Pharmacogenomics plays an important role in the bioactivation...

- Rebuilding the world one pixel at a time - Who says Rome wasn't built in a day? With the muscle of about 500 computers and 150,000 still images, Steve Seitz, a professor in the Department of Computer Science and Engineering at the University of Washington's Seattle campus, and his colleagues have reconstructed many of Rome's famous landmarks in just 21 hours. For more Science Nation, visit: http://www.nsf.gov/news/special_reports/science_nation/index.jsp

David Gordon from the University of Washington speaks at the "Sequencing, Finishing, Analysis in the Future" meeting in Santa Fe, NM on May 29, 2009.

Evan Eichler, Howard Hughes Medical Investigator at the University of Washington, gives the May 28, 2009 keynote speech at the "Sequencing, Finishing, Analysis in the Future" meeting in Santa Fe, NM. Part 2 of 2.

Evan Eichler, Howard Hughes Medical Investigator at the University of Washington, gives the May 28, 2009 keynote speech at the "Sequencing, Finishing, Analysis in the Future" meeting in Santa Fe, NM. Part 1 of 2.

Ginger Armbrust from the University of Washington spoke about diatom genomics on March 26, 2009 at the DOE JGI User Meeting.